Colin ORFORD,Cyril CLARKE,Colm FARRELL,Jacqueline PARKIN,Stefan DE BUCK
申请号：
US16793922
公开号：
US20200281896A1
申请日:
2020.02.18
申请国别(地区):
US
年份:
2020
代理人:
摘要：
This invention relates to a novel dosage regimen for administration of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide or a pharmaceutically acceptable derivative thereof, namely in the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD).
